Hypera SA Valuation
| HYPMY Stock | USD 3.48 0.13 3.88% |
At this time, the firm appears to be overvalued. Hypera SA retains a regular Real Value of $3.27 per share. The prevalent price of the firm is $3.48. Our model calculates the value of Hypera SA from evaluating the firm fundamentals such as Current Valuation of 6.39 B, return on asset of 0.0686, and Return On Equity of 0.16 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Hypera SA's price fluctuation is relatively risky at this time. Calculation of the real value of Hypera SA is based on 3 months time horizon. Increasing Hypera SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hypera SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hypera Pink Sheet. However, Hypera SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.48 | Real 3.27 | Hype 3.48 |
The intrinsic value of Hypera SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Hypera SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Hypera SA helps investors to forecast how Hypera pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hypera SA more accurately as focusing exclusively on Hypera SA's fundamentals will not take into account other important factors: Hypera SA Total Value Analysis
Hypera SA is currently expected to have takeover price of 6.39 B with market capitalization of 5.55 B, debt of 6.8 B, and cash on hands of 1.5 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Hypera SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.39 B | 5.55 B | 6.8 B | 1.5 B |
Hypera SA Investor Information
The book value of the company was currently reported as 16.57. The company last dividend was issued on the 29th of December 2022. Based on the key measurements obtained from Hypera SA's financial statements, Hypera SA is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Hypera SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hypera SA has an asset utilization ratio of 29.96 percent. This suggests that the Company is making $0.3 for each dollar of assets. An increasing asset utilization means that Hypera SA is more efficient with each dollar of assets it utilizes for everyday operations.Hypera SA Ownership Allocation
Hypera SA has a total of 631.94 Million outstanding shares. Roughly 99.97 (percent) of Hypera SA outstanding shares are held by general public with 0.03 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Hypera SA Profitability Analysis
The company reported the revenue of 5.94 B. Net Income was 1.21 B with profit before overhead, payroll, taxes, and interest of 3.8 B.About Hypera SA Valuation
Our relative valuation model uses a comparative analysis of Hypera SA. We calculate exposure to Hypera SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hypera SA's related companies.It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypermarcas ADR operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9000 people.
8 Steps to conduct Hypera SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Hypera SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Hypera SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Hypera SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Hypera SA's revenue streams: Identify Hypera SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Hypera SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Hypera SA's growth potential: Evaluate Hypera SA's management, business model, and growth potential.
- Determine Hypera SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Hypera SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Hypera SA Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 639.5 M | |
| Quarterly Earnings Growth Y O Y | 1.281 | |
| Forward Price Earnings | 13.986 | |
| Retained Earnings | 4.4 B |
Additional Tools for Hypera Pink Sheet Analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.